Maintenance of Platelet Inhibition With Cangrelor

Completed · Phase 2 · Has a placebo group

Conditions studied: Acute Coronary Syndrome (ACS)

In brief

The purpose of this study is to demonstrate that patients receiving cangrelor infusion before coronary artery bypass grafting have an acceptable safety profile and can undergo surgery without excessive bleeding peri-operatively.

Key facts

Study ID

NCT00767507

Run by

The Medicines Company

People needed

221

Starts

2008-10-01

Expected to finish

2011-07-01

Last updated by the study team

2014-04-04

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Written informed consent
• 18 Years of Age
• Non emergent coronary bypass graft surgery
• Received a thienopyridine within 48 hours prior to enrollment

You may not qualify if…

• Confirmed or suspected pregnancy
• Cerebrovascular accident within one yar
• Intracranial neoplasm
• History of bleeding diathesis
• Thrombocytopenia

Where it is running

• Scripps Clinic / Scripps Green Hospital — La Jolla, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.